Skip to main content
BioMaxima S.A. logo

BioMaxima S.A. — Investor Relations & Filings

Ticker · BMX ISIN · PLBIOMX00015 LEI · 2594007GAALFMXP4YB89 WAR Manufacturing
Filings indexed 616 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country PL Poland
Listing WAR BMX

About BioMaxima S.A.

https://www.biomaxima.com/

BioMaxima S.A. is a manufacturer specializing in in-vitro diagnostics. The company's primary activities include the development and production of a wide range of products for laboratory diagnostics, with a focus on clinical microbiology. Key product categories include microbiological media, various diagnostic reagents, and specialized laboratory equipment. In addition to its manufacturing operations, BioMaxima also serves as a distributor for products from other global diagnostics firms. The company is actively involved in product innovation, including the development of Minimum Inhibitory Concentration (MIC) tests for antibiotic susceptibility testing.

Recent filings

Filing Released Lang Actions
Podpisy do Sprawozdania Zarządu
Regulatory Filings
2026-04-30 Polish
Sprawozdanie Zarządu z działalności grupy
Regulatory Filings
2026-04-30 Polish
Podpisy do SSF
Regulatory Filings
2026-04-30 Polish
Skonsolidowane sprawozdanie finansowe
Regulatory Filings
2026-04-30 Polish
List Prezesa Zarządu
Regulatory Filings
2026-04-30 Polish
Podpisanie znaczącej umowy - Content (PL)
Regulatory Filings Classification · 85% confidence The text is a brief announcement by the Management Board informing investors of a new supply contract won via tender. It is not an annual or interim report, nor a financing or share transaction, but a general regulatory update on a material contract. It therefore falls under the fallback category for miscellaneous regulatory filings (RNS).
2026-04-17 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.